backtop


Print 22 comment(s) - last by JonnyDough.. on Nov 10 at 2:42 PM


  (Source: topnews.in)
Over the course of Phase I, patients have not experienced negative effects while taking SAV001-H

The first HIV vaccine for prevention has had a successful Phase I Clinical Trials in the United States, and is preparing to move on to Phase II and Phase III. 

The preventative HIV vaccine (called SAV001-H) was developed by Dr. Chil-Yong Kang and a team of researchers at the University of Western Ontario's Schulich School of Medicine & Dentistry as well as researchers from Sumagen Co. Ltd. Unlike other HIV vaccines that underwent clinical trials, SAV001-H contains a killed whole HIV-1 rather than just one specific part of HIV as an antigen or genetic vaccine using recombinant DNA. 

Phase I of clinical trials for the first HIV preventative vaccine started in March 2012. Infected men and women ranging from 18-50 years of age were separated into two groups, where one received SAV001-H and the other a placebo. 

Over the course of Phase I, patients have not experienced negative effects while taking SAV001-H. This includes signs/symptoms, laboratory toxicities and local reactions. 

"We have proven that there is no safety concern of SAV001-H in human administration and we are now prepared to take the next steps towards Phase II and Phase III clinical trials," said Dr. Dong Joon Kim, spokesperson for Sumagen. "We are delighted to be one step closer to the first commercialized HIV vaccine."

Also, interim data showed a large increase in HIV-1 antibody formations after SAV001-H was given to patients. 

The humoral immune responses still need to be analyzed, but these initial results are promising. This could make SAV001-H the first commercially available HIV prevention vaccine in the United States at some point. 

There has been great progress for preventative HIV drugs in the U.S. lately. Back in July, the U.S. Food and Drug Administration (FDA) approved the HIV prevention pill called "Truvada." 

Source: University of Western Ontario



Comments     Threshold


This article is over a month old, voting and posting comments is disabled

RE: Volunteers wanted!
By inperfectdarkness on 11/8/2012 2:12:28 AM , Rating: 2
They are probably going to test largely in Africa. No offense to anyone reading this--Africa has the world's largest HIV-positive population. Finding test subjects who will potentially be exposed to HIV in the near future is going to be much easier there.


RE: Volunteers wanted!
By inperfectdarkness on 11/8/2012 2:15:34 AM , Rating: 2
Exempting So-Cal's thousands of porn stars, of course.


RE: Volunteers wanted!
By fishman on 11/8/2012 6:59:22 AM , Rating: 5
Actually, the rate of AIDS infection in the porn industry is very, very low.


RE: Volunteers wanted!
By kattanna on 11/8/2012 11:10:54 AM , Rating: 2
quote:
They are probably going to test largely in Africa.


and hopefully.. when they do get a viable vaccine, it will also be one of the first places to be widely deployed..freely.

I could actually see it as something the gates foundation would pick up the bill for.


RE: Volunteers wanted!
By Master Kenobi (blog) on 11/8/2012 6:06:26 PM , Rating: 1
There's a good chance of it. Gates won't jump on it unless the data looks good. He's a skeptic and for good reason.


RE: Volunteers wanted!
By JonnyDough on 11/10/2012 2:42:28 PM , Rating: 2
The really beautiful thing about research is that you could start a company in Africa with the data, without transporting the actual virus there. If the FDA drags their feet, it could easily become a patent in some other country first. This happens all the time.


"I f***ing cannot play Halo 2 multiplayer. I cannot do it." -- Bungie Technical Lead Chris Butcher














botimage
Copyright 2014 DailyTech LLC. - RSS Feed | Advertise | About Us | Ethics | FAQ | Terms, Conditions & Privacy Information | Kristopher Kubicki